Results 141 to 150 of about 12,529 (195)

[Current Status of Passive Immunization Against COVID in Respiratory Patients]. [PDF]

open access: yesOpen Respir Arch
Mora Cuesta VM   +2 more
europepmc   +1 more source

[Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?] [PDF]

open access: yesRev Neurol, 2022
López-Moreno Y   +3 more
europepmc   +1 more source

[Adaptation of headache units in Andalusia to the COVID-19 pandemic. Analysis of the Andalusian Neurology Society's Headache Study Group]. [PDF]

open access: yesRev Neurol, 2022
Lamas-Pérez R   +5 more
europepmc   +1 more source

[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]. [PDF]

open access: yesEnferm Infecc Microbiol Clin, 2022
Pinargote-Celorio H   +13 more
europepmc   +1 more source

Anticuerpos monoclonales en el tratamiento del cáncer

open access: yes, 2016
En la actualidad el cáncer es una patología muy prevalente, pero gracias al conocimiento de su biología se ha conseguido desarrollar nuevos fármacos, entre los que destacan los anticuerpos monoclonales (mabs). Estos son proteínas inmunitarias producidas por ingeniería genética, las cuales se van a unir a ciertas dianas presentes en la célula tumoral y ...
openaire   +1 more source

Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. [PDF]

open access: yesRev Neurol
García-Estévez DA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy